HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

Email Updates

Receive our lunchtime briefing straight to your inbox

More in this Section

Raids in Waterford and Tallaght lead to cocaine and ecstasy seizures

Body recovered from canal in Killaloe

Cork mother 'crushed' as HSE rejects daughter Ava's application for medical cannabis

Coroner echoes sister's plea for improved education on drugs at Alex Ryan inquest


Today's Stories

Drowned boy could not use own armbands, father told

Row may have led to man’s death in Fermoy

Fine Gael set to have new leader by Easter

Tusla chief vows no repeat of Maurice McCabe scenario

Lifestyle

It's almost time - so who’ll win the Oscars?

Notes On A Rave explores early days of Irish underground dance music scene

A question of taste: Cork actor and puppeteer Dominic Moore

Whimsical, subversive, darkly romantic: The many styles of Ruth Negga

More From The Irish Examiner